✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Talinolol is an investigational drug.
There have been 4 clinical trials for Talinolol. The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 2007.
The most common disease conditions in clinical trials are Obesity, Morbid and [disabled in preview]. The leading clinical trial sponsors are University Medicine Greifswald, Matthias Schwab, and Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH.
Recent Clinical Trials for Talinolol
|Open Label Study for the Functional Characterization of Drug Metabolism and Transport||Matthias Schwab||Phase 1|
|Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water||University Medicine Greifswald||Phase 1|
|Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics||Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||Phase 1|